
As merely a dull-witted heart attack survivor with a relatively recent interest in scientific research (and only because it can influence how my doctor and yours practice medicine), I like to think that university researchers are a noble lot. But in an essay called The Dawn of McScience, Dr. Richard Horton delivers a surprising indictment of academic research.
In his New York Review of Books column about the book called Science in the Private Interest, he cites its author Dr. Sheldon Krimsky of Tufts University School of Medicine, who lumps universities in with industry like so:
“Universities have become little more than instruments of wealth.
“This shift in the mission of academia works against the public interest. Universities have sacrificed their larger social responsibilities to accommodate a new purpose – the privatization of knowledge – by engaging in multimillion-dollar contracts with industries that demand the rights to negotiate licenses from any subsequent discovery.” Continue reading
Whenever you read a medical journal article with a title like Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies, you know it’s a bad day for patients.


Drug giant AstraZeneca has been working on a back room legal settlement deal with the U.S. government since last fall. And according to a New York Times investigation, the company has earmarked $520 million for the purpose.